- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02245958
A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
January 6, 2016 updated by: Allergan
This study is a retrospective chart review to evaluate the doses of botulinum Type A toxins BOTOX® (onabotulinumtoxinA) and Xeomin® (incobotulinumtoxinA) used for the treatment of Cervical Dystonia and Blepharospasm in clinical practice.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
44
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Colonia Roma Z.P., Mexico, 06700
-
-
-
-
-
Wakefield, United Kingdom, WF1 4DG
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants with cervical dystonia or blepharospasm previously treated with Xeomin® and BOTOX® in clinical practice.
Description
Inclusion Criteria:
- Confirmed primary diagnosis of idiopathic cervical dystonia or blepharospasm for at least 2 years
- Treatment with Xeomin® and BOTOX® for at least 2 years each.
Exclusion Criteria:
- Having a neuromuscular junction transmission disorder or taking any medications that could affect neuromuscular junction transmission
- Previous surgical procedure involving bone or muscle for the management of cervical dystonia or blepharospasm.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
BOTOX®
Retrospective chart review of doses of BOTOX® (onabotulinumtoxinA) used as standard of care in clinical practice.
No treatment (intervention) was administered.
|
No treatment (intervention) was administered.
|
Xeomin®
Retrospective chart review of doses of Xeomin® (incobotulinumtoxinA) used as standard of care in clinical practice.
No treatment (intervention) was administered.
|
No treatment (intervention) was administered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Dose of Botulinum Toxin Used to Treat Cervical Dystonia
Time Frame: 4 Years
|
4 Years
|
Dose of Botulinum Toxin Used to Treat Blepharospasm
Time Frame: 4 Years
|
4 Years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Botulinum Toxin Inter-injection Intervals
Time Frame: 4 Years
|
4 Years
|
Number of Participants with Adverse Events
Time Frame: 4 Years
|
4 Years
|
Annual Botulinum Toxin Dose per Patient
Time Frame: 4 Years
|
4 Years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
September 18, 2014
First Submitted That Met QC Criteria
September 18, 2014
First Posted (Estimate)
September 22, 2014
Study Record Updates
Last Update Posted (Estimate)
January 8, 2016
Last Update Submitted That Met QC Criteria
January 6, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GMA-US-NEU-0271
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Dystonia
-
Fondation Ophtalmologique Adolphe de RothschildCompletedCervical Dystonia, PrimaryFrance
-
University of FloridaBachmann Strauss Dystonia & Parkinson Foundation, Inc.Completed
-
University Hospital, MontpellierTerminatedSpasticity | Isolated Cervical Dystonia | Complex DystoniaFrance
-
University of Colorado, DenverCompleted
-
University of FloridaAmerican Brain Foundation; NeuroneticsCompletedDystonia | Primary Cervical DystoniaUnited States
-
University Hospital, LilleCompletedIdiopathic Cervical DystoniaFrance
-
IpsenCompletedIdiopathic Cervical DystoniaBelgium, France, United Kingdom, Portugal, Germany, Australia, Czechia, Netherlands, Russian Federation
-
Fondazione Don Carlo Gnocchi OnlusUnknownCervical Dystonia,PrimaryItaly
-
University of FloridaDystonia Medical Research FoundationTerminated
-
Prof. Dr. Şehim KutlayRecruitingDystonia, CervicalTurkey
Clinical Trials on No Intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Wright State UniversityCompleted